How does initial treatment choice affect short‐term and long‐term costs for clinically localized prostate cancer?

Data regarding costs of prostate cancer treatment are scarce. This study investigates how initial treatment choice affects short‐term and long‐term costs.

[1]  C. Mackenzie,et al.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.

[2]  R. Deyo,et al.  Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. , 1992, Journal of clinical epidemiology.

[3]  M. Gold.  Cost-effectiveness in health and medicine , 2016 .

[4]  J H Wasson,et al.  Assessment of the feasibility and impact of shared decision making in prostate cancer. , 1998, Urology.

[5]  G. Imbens.  The Role of the Propensity Score in Estimating Dose-Response Functions , 1999 .

[6]  R D Etzioni,et al.  Obtaining long-term disease specific costs of care: application to Medicare enrollees diagnosed with colorectal cancer. , 1999, Medical care.

[7]  J L Warren,et al.  Development of a comorbidity index using physician claims data. , 2000, Journal of clinical epidemiology.

[8]  P. Carroll,et al.  Relationship of first-year costs of treating localized prostate cancer to initial choice of therapy and stage at diagnosis: results from the CAPSURE database. , 2001, Urology.

[9]  Jonathan H Sunshine,et al.  Comparing the costs of radiation therapy and radical prostatectomy for the initial treatment of early-stage prostate cancer. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  Ruth Etzioni,et al.  Estimating Health Care Costs Related to Cancer Treatment From SEER-Medicare Data , 2002, Medical care.

[11]  E. Foster,et al.  Propensity Score Matching: An Illustrative Analysis of Dose Response , 2003, Medical care.

[12]  J. Stanford,et al.  Five-year outcomes after prostatectomy or radiotherapy for prostate cancer: the prostate cancer outcomes study. , 2004, Journal of the National Cancer Institute.

[13]  M. Morrow,et al.  Five-Year Outcomes After Prostatectomy or Radiotherapy for Prostate Cancer: The Prostate Cancer Outcomes Study , 2006 .

[14]  Natalia Sadetsky,et al.  Cumulative cost pattern comparison of prostate cancer treatments , 2007, Cancer.

[15]  M. Litwin,et al.  Health care cost associated with prostate cancer, androgen deprivation therapy and bone complications. , 2006, The Journal of urology.

[16]  Ruth Etzioni,et al.  Trends in Treatment Costs for Localized Prostate Cancer: The Healthy Screenee Effect , 2007, Medical care.

[17]  J. Warren,et al.  Costs of cancer care in the USA: a descriptive review , 2007, Nature Clinical Practice Oncology.

[18]  E. Lamont,et al.  Evaluation of trends in the cost of initial cancer treatment. , 2008, Journal of the National Cancer Institute.

[19]  Sam S. Chang,et al.  A critical review of clinical practice guidelines for the management of clinically localized prostate cancer. , 2008, The Journal of urology.

[20]  Lorenzo Moreno,et al.  Propensity Score Matching , 2008 .

[21]  Bhagwan Satiani.  A Medicare primer. , 2009, Journal of vascular surgery.

[22]  M. Stokes,et al.  First-year costs of treating prostate cancer: estimates from SEER-Medicare data , 2009, Prostate Cancer and Prostatic Diseases.